These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6160241)

  • 21. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
    Ekert H; Waters KD; Smith PJ; Toogood I; Mauger D
    J Clin Oncol; 1988 Dec; 6(12):1845-50. PubMed ID: 3058876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 24. Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
    Hoppe RT; Portlock CS; Glatstein E; Rosenberg SA; Kaplan HS
    Cancer; 1979 Feb; 43(2):472-81. PubMed ID: 369676
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
    Santoro A; Bonadonna G; Bonfante V; Valagussa P
    N Engl J Med; 1982 Apr; 306(13):770-5. PubMed ID: 6174865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of recurrences of Hodgkin's disease in children].
    Armata J; Moryl-Bujakowska A
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1301-4. PubMed ID: 6201835
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination chemotherapy of acute leukemia and Hodgkin's disease.
    Frei E
    JAMA; 1972 Nov; 222(9):1168. PubMed ID: 4678057
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
    Kotlarek-Haus S; Gabryś K; Potoczek S
    Pol Arch Med Wewn; 1995 Mar; 93(3):228-33. PubMed ID: 7479244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 31. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ChlVPP: reducing toxicity in the treatment of Hodgkin's disease.
    Mansi JL
    Eur J Cancer; 1992; 28A(8-9):1411-3. PubMed ID: 1515260
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 34. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiotherapy for advanced Hodgkin's disease.
    Gupta T; Sanghavi V; Laskar S
    N Engl J Med; 2003 Sep; 349(12):1187-8; author reply 1187-8. PubMed ID: 13679537
    [No Abstract]   [Full Text] [Related]  

  • 38. Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
    Radford JA; Crowther D; Rohatiner AZ; Ryder WD; Gupta RK; Oza A; Deakin DP; Arnott S; Wilkinson PM; James RD
    J Clin Oncol; 1995 Sep; 13(9):2379-85. PubMed ID: 7666097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications.
    Bang SM; Cheong JW; Yang WI; Hahn JS
    Yonsei Med J; 2005 Jun; 46(3):425-30. PubMed ID: 15988816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
    Harding MJ; McNulty LJ; Paul J; Lee F; Brown A; Soukop M
    Eur J Cancer; 1991; 27(8):1002-6. PubMed ID: 1832882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.